SCHEDULE: FMR LLC Discloses Stake in Biogen Inc.

FMR LLC, along with Abigail P. Johnson, has filed a Schedule 13G, reporting beneficial ownership of 12,807,541.50 shares of Biogen Inc. common stock, representing 8.7% of the class.

Summary

• FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, indicating their beneficial ownership of Biogen Inc. common stock.
• The filing reports a total of 12,807,541.50 shares, which constitutes 8.7% of Biogen Inc.'s outstanding common stock.
• This filing is an amendment (Amendment No. 1) and the event date requiring the filing is March 31, 2026.
• FMR LLC is identified as a holding company (HC), and Abigail P. Johnson is identified as an insider (IN).
• The filing confirms sole voting power and sole dispositive power for a significant portion of the shares held by FMR LLC.
• Several subsidiaries of FMR LLC, including FIAM LLC, Fidelity Diversifying Solutions LLC, Fidelity Institutional Asset Management Trust Company BK, Fidelity Management & Research Company LLC, Fidelity Management Trust Company BK, FMR Investment Management (UK) Limited, and Strategic Advisers LLC, are involved in the beneficial ownership.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. Schedule 13G filings are routine disclosures of beneficial ownership and do not inherently signal positive or negative developments for the company itself, but rather reflect investment positions.

Positives

• FMR LLC and Abigail P. Johnson have disclosed a significant beneficial ownership stake of 8.7% in Biogen Inc., providing transparency to the market.
• The filing indicates FMR LLC has sole voting power and sole dispositive power over a substantial number of shares, suggesting clear control over their investment decisions.
• The joint filing by FMR LLC and Abigail P. Johnson, along with the Rule 13d-1(k)(1) agreement, demonstrates a coordinated approach to reporting beneficial ownership.

Negatives

• The filing does not contain any negative financial performance indicators or operational challenges for Biogen Inc. as it is a Schedule 13G filing focused on ownership.

Risks

• The filing does not explicitly mention any risks associated with Biogen Inc. or the ownership stake.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Biogen Inc.'s future performance.

Management Comments

• FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by FMR LLC, a major investment management firm, indicates a significant institutional holding in Biogen Inc., a leading biotechnology company. Such filings are common for large asset managers and reflect their investment strategies and portfolio allocations within the pharmaceutical and biotechnology sector.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant institutional ownership, which can influence market perception and trading activity.
• Biogen Inc.: The filing confirms FMR LLC as a substantial shareholder, which could imply a stable or growing institutional investor base.

Next Steps

• FMR LLC and Abigail P. Johnson will continue to hold and potentially manage their investment in Biogen Inc. according to their investment strategies.
• Future amendments to this Schedule 13G will be filed if there are material changes in beneficial ownership.

Key Dates

Keywords

Biogen Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Investment, SEC Filing, Fidelity